Dr. Mrinalini Kannan
Senior Resident
Department : Obstetrics and Gynecology
Email : dr.mrinalinikanna@gmail.com
Introduction:
I Dr. Mrinalini Kannan recently completed my Post Graduate Degree in MS Obstetrics and Gynaecology from SRM Medical College and Hospital Chennai in the year 2024. I am Ability to handle High risk cases, coordinate and work as a team.
Educational Qualifications:
| Degree | Year | Name of College & University | Registration number with date of registration |
Name of State Medical council |
|---|---|---|---|---|
| MBBS | 2018 | Saveetha Medical College and Hospital, Chennai. Saveetha University | 143965 (19.02.2020) | Tamilnadu Medical Council |
| MS | 2024 | SRM Medical College Hospital and Research Centre, Kattankulathur. SRM University | 143965 | Tamilnadu Medical Council |
Details of Teaching experience till date:
| Designation | Department | Institution | From | To | Total |
|---|---|---|---|---|---|
| Junior Resident | Obstetrics & Gynaecology | SRM Medical College Hospital and Research Centre, Kattankulathur. | 28.02.2022 | 27.02.2025 | 3 Years |
| Senior Resident | Obstetrics & Gynaecology | SRM Medical College Hospital and Research Centre, Kattankulathur. | 27.03.2025 | Till Date |
Research & Publications :
- Mrinalini Kannan, Sajeetha Kumari, R and Vinodhini Shanmugam "Correlation of maternal platelet to lymphocyte ratio and neutrophile to lymphocyte ratio, C-reactive protein with gestational age at delivery and fetal outcome- aprospective observational study from tertiary care cener"Journal of Clinical Epidemiology and Global Health, 28, 2024, 1-6 June 2024 Clinical Epidemiology and Global Health 28(8):101687 DOI: 10.1016/j.cegh.2024.101687 License: CC BY-NC-ND 4.0
Awards & Acheivements :
- Received 2nd prize in the poster presentation for the paper titled "Comparison of efficacy of oral Amlodipine vs oral labetalol in controlling blood pressure in women with postpartum hypertension- a pilot study" in the "7th advance course in clinical pharmacology 2022" held at SRM Medical College Hospital and Research Institute during 2022.